KEYBANK NATIONAL ASSOCIATION/OH
BankPosition in PTGX — Protagonist Therapeutics, Inc
CIK 1089877
BROOKLYN, OH
Position in PTGX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$612,531
+$160,787 QoQ
Shares Held
4,997
+16.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#199
of 341 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KEYBANK NATIONAL ASSOCIATION/OH holds $23,001,658 across 27 Biotechnology names. PTGX ranks #11 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,934 | $4,934,515 | |
| 2 | RPRX |
Royalty Pharma plc
|
54,814 | $3,073,420 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
10,084 | $2,429,940 | |
| 4 | ARGX |
Argenx SE
|
1,718 | $1,593,908 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,132 | $1,329,386 | |
| 6 | GMAB |
Genmab A/S
|
31,068 | $853,437 | |
| 7 | INSM |
INSMED Inc
|
7,252 | $773,207 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
2,049 | $647,668 |
All Filings in PTGX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $612,531 | 4,997 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $451,744 | 4,286 | Shares | Defined | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||